• 11520 Citations
  • 58 h-Index
1976 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where John N Galgiani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Coccidioidomycosis Medicine & Life Sciences
Coccidioides Medicine & Life Sciences
Ketoconazole Medicine & Life Sciences
Infection Medicine & Life Sciences
Fluconazole Medicine & Life Sciences
Amphotericin B Medicine & Life Sciences
Antifungal Agents Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1995 2015

Phase II Clinical Trials
Coccidioidomycosis
Pneumonia
Pharmaceutical Preparations
Infection
Coccidioidomycosis
Pharmacology
Mycoses
Pharmaceutical Preparations
Orphan Drug Production
Coccidioidomycosis
Coccidioides
Therapeutics
Pharmacokinetics
Chitin Synthase

Research Output 1976 2019

  • 11520 Citations
  • 58 h-Index
  • 223 Article
  • 4 Conference contribution
  • 2 Chapter
  • 2 Review article
1 Citation (Scopus)

Characterizing in vitro spherule morphogenesis of multiple strains of both species of Coccidioides

Mead, H. L., Teixeira, M. D. M., Galgiani, J. N. & Barker, B. M., Jun 1 2019, In : Medical mycology. 57, 4, p. 478-488 11 p.

Research output: Contribution to journalArticle

Open Access
Coccidioides
Morphogenesis
Coccidioidomycosis
Growth
Inhalation
1 Citation (Scopus)

Glucan-chitin particles enhance Th17 response and improve protective efficacy of a multivalent antigen (rCpa1) against pulmonary Coccidioides posadasii infection

Hung, C. Y., Zhang, H., Castro-Lopez, N., Ostroff, G. R., Khoshlenar, P., Abraham, A., Cole, G. T., Negron, A., Forsthuber, T., Peng, T., Galgiani, J. N., Ampel, N. M. & Yu, J. J., Nov 1 2018, In : Infection and Immunity. 86, 11, e00070-18.

Research output: Contribution to journalArticle

Coccidioides
Chitin
Glucans
Vaccines
Antigens
1 Citation (Scopus)

Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity

Shubitz, L., Powell, D. A., Trinh, H. T., Lewis, M. L., Orbach, M. J., Frelinger, J. A. & Galgiani, J. N., May 31 2018, In : Vaccine. 36, 23, p. 3375-3380 6 p.

Research output: Contribution to journalArticle

Coccidioides
Spores
Immunity
Vaccination
spores
17 Citations (Scopus)

Risk factors for disseminated coccidioidomycosis, United States

Odio, C. D., Marciano, B. E., Galgiani, J. N. & Holland, S. M., Feb 1 2017, In : Emerging Infectious Diseases. 23, 2, p. 308-311 4 p.

Research output: Contribution to journalArticle

Coccidioidomycosis
Immunocompromised Host
Interleukin-12
Interferons
Infection
86 Citations (Scopus)

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis

Galgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Geertsma, F., Hoover, S. E., Johnson, R. H., Kusne, S., Lisse, J. R., MacDonald, J. D., Meyerson, S. L., Raksin, P. B., Siever, J., Stevens, D. A., Sunenshine, R. & Theodore, N., Sep 15 2016, In : Clinical Infectious Diseases. 63, 6, p. e112-e146

Research output: Contribution to journalArticle

Coccidioidomycosis
Practice Guidelines
Infection
Southwestern United States
Physicians